The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I recollect they previously released glossed up info after the event. Presumably to avoid being accused of withholding sensitive information.
We already have had the early Jan RNS to update the market prior to SD.
This sounds like the Dox resistance of cancer cells that I came across a few weeks ago. Papers going back 20 years. I wondered if AVA6k could be beneficial to overcoming this resistance and why I had not read about it before. It really sounds like a good opportunity for AVA6k to peel back the resistance layers on a daily basis, rather than 3 weeks between doses. Maybe one day Avacta will disclose something about this.
Lol. Many buttons pressed. No useful discussion as usual. Potty mouths to impress parents. A few good reasons to question assumptions rejected. Enjoy your restless night.
Follow Rippedtrousers advice and use the filter on/off
It seems we could have been told more early January. Why was such information held back? I’m concerned because every time I look at my box of LFTs in my junk cupboard I’m reminded they were sold to me as being the best because they used the exquisite Affimer and then finding out that in fact they contained the wrong antibodies.